Practice Newsletter

Remote Monitoring to Track Fellow Eye AMD Progression

December 2022

With the advent of longer acting wet AMD treatments, patients with unilateral wet AMD whose fellow eyes are monitored for progression from intermediate AMD to wet AMD during injection visits are at increased risk of experiencing undetected disease progression because more durable treatments lead to a reduced number of office visits.

Miguel Busquets, MD of Retina Associates of Kentucky discusses how ForeseeHome for fellow eye AMD progression can help.

Retinal Physician | November 2022

Read the article

Related News

View Latest News
Practice Newsletter
A “Great” Program – The ForeseeHome Patient NPS Survey Results
March 2024

Every year we ask patients “how likely are you to recommend ForeseeHome to a friend or colleague” as part of our outreach to determine our Net Promoter Score®, or NPS®.

Practice Newsletter
Doctors Give ForeseeHome High Marks
February 2024

We recently asked our referring doctors “how likely are you to recommend ForeseeHome to other physicians for their patients” as part of our outreach to determine our Net Promoter Score®, or NPS®.

Practice Newsletter
ARVO 2023 Poster by Medical Directors George Sanborn, MD & Jennifer Jacobs, MD
May 2023

A tele-ophthalmology model for remote monitoring of patients with intermediate age-related macular degeneration.